Cargando…

Optimum Use of Acute Treatments for Hereditary Angioedema: Evidence-Based Expert Consensus

Acute treatment of hereditary angioedema due to C1 inhibitor deficiency has become available in the last 10 years and has greatly improved patients’ quality of life. Two plasma-derived C1 inhibitors (Berinert and Cinryze), a recombinant C1 inhibitor (Ruconest/Conestat alpha), a kallikrein inhibitor...

Descripción completa

Detalles Bibliográficos
Autor principal: Longhurst, Hilary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857575/
https://www.ncbi.nlm.nih.gov/pubmed/29594115
http://dx.doi.org/10.3389/fmed.2017.00245